ABSTRACT
INTRODUCTION Acute Myocardial Infarction Pathophysiology
Acute coronary thrombosis, resulting in total occlusion of acoronary artery, leads to ST-segment elevation myocardial infarction (STEMI) (1) . Exposition of the lipid-rich core, after atherosclerosis plaque rupture/erosion into the arterial lumen triggers the formation of unstable platelet aggregates, which may lead to intermittent reduction in coronary flow and cause distal embolization (2) .
There are two basic types of acute myocardial infarction, based on pathology:
• Transmural: associated with atherosclerosis, involving a major coronary artery. It can be sub classified into anterior, posterior, inferior, lateral or sepal. Transmural infarcts extend, through the whole thickness of the heart muscle and are usually a result of complete occlusion of the area's blood supply. (3) In addition, on ECG, ST elevation and Q waves are seen.
• Subendocardial: involving a small area in the subendocardial wall of the left ventricle, ventricular septum, or papillary muscles. The subendocardial area is particularly susceptible to ischemia. (4) 
Risk Stratification
Risk stratification of patients with STEMI can be based on physical examination findings at the time of presentation. The Killip classification is easy to use and provides a rapid method of risk-stratifying patients, in the emergency department, although the mortality rates may overestimate those in the modern era). (5) The discomfort is persistent (unrelieved by rest or nitrates); is frequently associated with diaphoresis, nausea, dyspnea, and fear of impending death; and usually achieves maximum intensity over several minutes, at least 20% of patients with AMI, however, may lack classic chest discomfort and instead have atypical symptoms (6) .
Electrocardiographic Manifestations
All patients presenting to an emergency department with chest pain or other symptoms, concerning for MI should have an electrocardiogram (ECG) performed and interpreted within 10 minutes of arrival. (7) . The ECG remains the single most useful diagnostic test in cases of suspected ACS and facilitates segregation of patients into STEMI and NSTEACS pathways. (8) . In NSTEACS, findings may be more variable and commonly include ST-segment depression and T-wave inversion. Criteria for acute ischemia have been validated and include ST-segment elevation of _1 mm that is concordant with the main vector of the QRS complex; ST-segment depression of _1 mm in leads V1, V2, or V3; and ST-segment elevation of _5 mm that is discordant with the main vector of the QRS complex.(9)
Serum Markers in Acute Myocardial Infarction
Damaged cardiomyocytes, release several proteins in the circulation, including myoglobin, creatine kinase (CK), and its MB isoenzyme (CK-MB), cardiac troponin (cTn) I and T, aspartate aminotransferase, and lactate dehydrogenase.
The cTn biomarkers, are preferred based on superior sensitivity and specificity for cardiac injury and robust prognostic value, across the spectrum of ACS.(10-11)
Stress Hyperglycemia
Studies have shown that, an increase in glucose concentrations after admission for AMI and the overall glycemic load, after admission determine morbidity and mortality in this condition (12, 13) . Recent guidelines have suggested that, glucose levels should be maintained below 140 mg/dl in subjects, with STEMI (14) . Because, atherothrombosis is a proinflammatory condition, it is important to describe the pro-inflammatory effects of glucose and the anti-inflammatory and other relevant effects of insulin, that are independent of its glucose lowering effect (15) . Glucose induces reactive oxygen species generation, an increase in the expression of p47phox, as a marker of nicotinamide adenine dinucleotide phosphate oxidase, the enzyme that generates superoxide from molecula oxygen. In addition, glucose induces, an increase in nuclear factor kappa B (NF_B) binding, a reduction in inhibitor _B_, an increase in activating protein-1 and matrix metalloproteinases, and an increase in early growth response-1 and tissue factor (15) . In STEMI, acute hyperglycemia is associated with an increase in no reflow, increased platelet aggregation, and increased left ventricular remodeling (15) .
Insulin, in contrast, suppresses reactive oxygen species generation, p47 phox; NF_B binding, early growth response-1 binding, tissue factor, and plasminogen activator inhibitor type 1 concentration (15). More recently, insulin has been shown to suppress the expression of toll-like receptors (TLR), in particular, TLR-2 and -4 (16) . Both are involved in the pathogenesis of insulin resistance, whereas TLR-2 is involved the mediation of ischemia reperfusion injury and is thus particularly relevant to patients with AMI. In addition, insulin is a vasodilator, induces nitric oxide generation and the endothelial form of nitric oxide synthase expression, and inhibits platelet aggregability, both in normal subjects and in patients, with acute coronary syndromes (15) .
Effect of Stress Hyperglycaemia in Acute Myocardial Infarction
An unusually high prevalence of glucosuria, in patients without diabetes who have acute myocardial infarction was noted, as far back as 1931. (17 
Aims of the Study
• To study the effect of stress hyperglycemia, on the development of cardiogenic shock, heart failure, arrhythmia, and death.
• To determine, whether the site of myocardial infarction has an effect on development of stress hyperglycemia.
• To determine whether this hyperglycemia occurs, more in patients who receive thrombolytic therapy or in those who do not receive it.
PATIENTS AND METHODS
This is a prospective randomized study had enrolled 92 patient with acute myocardial infarction in Baghdad teaching hospital (Emergency department, coronary care unit and medical ward) over 1 year from the first of December 2011 to the first of December 2012.
The patients had been studied without assessment of other risk factors for Ischemic heart diseases like hypertension, obesity, smoking, dyslipidemia and family history of ischemic heart diseases.
Exclusion criteria
• Patients with history of diabetes mellitus, heart failure, chronic renal failure
• Patients receiving steroid therapy.
• Patients with previous ECG finding of LBBB.
• Patients with previous ACS.
• HbA1c > 6.5. Random plasma glucose was done for each patient, by the usual laboratory method in the emergency department, at time of admission before receiving any treatment and repeated in the second day, after hospitalization (2nd day fasting blood glucose).
Admission hyperglycemia was diagnosed, if mean random glucose level on admission was ≥11.1mmol/L. Post admission hyperglycemia was diagnosed, if mean post admission fasting glucose level, calculated from glucose value on the morning after admission ≥7.8mmol/L. (27) (28) HbA1C level was measured in all patients, blood draw from patient and send to Baghdad teaching Laboratories.
All patients with HbA1c level > 6.5% were dropped from the study due to high probability to have undiagnosed diabetes.
(29)
The patients were divided into 2 groups: g`
Group 1: normoglycemic patients (no hyperglycaemia after AMI)

Group 2: stress hyperglycaemic patients (hyperglycaemia after AMI)
Echocardiography was done to all patients, with acute myocardial infarction in coronary care unit and systolic heart failure, considered to be present if the ejection fraction is less than 40% and may manifest as regional wall motion abnormalities. (30) The diagnosis of cardiogenic shock, depend on clinical examination like hypotension (systolic blood pressure <90 mmHg), cold clammy skin, rapid shallow breathing, drowsiness, irritability, confusion, oliguria (urine output<30 ml/hr) and supported, by echo cardiography. (31) The site of myocardial infarction was recorded for each patient (lateral, inferior, anterior or extensive infarction) according to electrocardiographic reading; where a serial standard 12 lead ECG remain useful method for the detection and localization of myocardial infarction. (32)
Statistical Analysis of the Data
By using SPSS, (statistical package for social sciences) version 19 software, for windows; Data of all patients were entered and analysed. Appropriate statistical tests were performed and multiple contingency tables had been conducted. Student (t)-test, was used to find the significance of differences inbetween groups in mean age, and Chi square test was used to compare frequencies and proportions (percentages). Level of significance was set at P. value ≤ 0.05 to be considered statistically significant and highly significant, if at P. value ≤ 0.01. Finally, the results were presented in tables and or figures. Four patients out of 60 (6%) in group-1 developed cardiogenic shock, compared to 8 patients out of 32 (25%) in group 2, p value <0.05, the prevalence of cardiogenic shock was significantly higher, in patients with stress hyperglycemia in table 3. The prevalence of arrythemias did not significantly differ between both groups (p value>0.05) and many different types of cardiac rhythm abnormalities were noticed, in table 5. 1.8 -16.3) ) P. value = 0.0038 highly significant
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DISCUSSIONS
The study showed that the incidence of heart failure and cardiogenic shock were more in patients with stress hyperglycemia and this is consistent with Bellodi G. et al. (33) , which showed that, hyperglycemia with acute myocardial infarction is associated with increased risk of heart failure and cardiogenic shock.
The high incidence of heart failure and cardiogenic shock can be explained by multiple reasons, including that hyperglycemia could reduce flow to the risk area (34) , resulting in greater myocardial damage, before the reperfusion (35) ,acute increase in bloodglucose levelworsen endothelial function (36) , therefore suggesting that, hyperglycemia induced endothelial dysfunction can also contributes to the damaging effect of hyperglycemia, during an acute myocardial infarction, acute hyperglycemia independently associated with impaired left ventricular function(37) and a large infarct size, due to an increased incidence of the no re-flow phenomenon (38) .
The study showed that, patients with extensive infarction seem to develop stress hyprglycemia, more than those patients with lateral, inferior, inferolateral or anterior myocardial infarction probably, due to large infarct size in those patients, with extensive infarction this consistent with Tansey MJ. et al. (39) This study showed that, stress hyperglycemia was not associated with an increased incidence of arrhythmia inconsistent with A. Sandaram et al. (40) showed that, hyperglycemia was associated with great erincidence of conductive defect and arrhythmia. Gokhroo R. et al. (41) showed that, in acute myocardial infarction, an increased plasma glucose level have been demonstrated to be capable of inducing, such electro phsyological alterations as to favour the occurrence of arrhythmias, whose outcome could be fatal. This is consistent with the evidence that, an acute increase in blood glucose level in normal subjects produces a significant QT prolongation (42) .
In this study, there were no significant differences in patients, who received thrombolytic therapy from those
